Note: Ingredients listed on restricted chemical lists
EC/CAS
219-371-7/2425-79-8
Name of the chemical
1,4-butanediol bis(2,3-epoxypropyl)ether
Concentration
10-30%
General Information
Version
3
Revision date
2022-10-05
Product name
Adhesive A50-A
1.2.1 Relevant identified uses
Liquid adhesive
Icons in SDS
Company Information
company name
Ru-bix Tooling Board
e-mail address of the competent person responsible for the Safety Data Sheet
ash.colvin@ru-bix.com
GHS Information
Signal word
Warning
Hazard Codes
Hazard statements (CLP)
H315, H317, H319, H332, H411
Hazard statements
Code
Statements
H315
Causes skin irritation
Section 2
SECTION 2: Hazards identification
2.1 Classification of the substance or mixture
Acute toxicity (inhaln), Category 4 H332
Physical hazards
Not Classified
Health hazards
Skin Irrit. 2 - H315: Eye Irrit. 2 - H319; Skin Sens. 1 - H317
Environmental hazards
Aquatic Chronic 2 - H411 Human health: The product is irritating to eyes and skin. May cause sensitisation by skin contact. Category 1, H317. Harmful if inhaled. Environmental: The product contains a substance which is toxic to aquatic organisms and which may cause long-term adverse effects in the aquatic environment.
Hazard statements
H315 Causes skin irritation. H317 May cause an allergic skin reaction. H319 Causes serious eye irritation. H411 Toxic to aquatic life with long lasting effects. Page: - 1 - H315 - Causes skin irritation. H317 - May cause an allergic skin reaction. H319 – Causes serious eye irritation. H332 – Harmful if inhaled. H411 – Toxic to aquatic life with long-lasting effects.
Signal word
Warning
Contains
1,4-bis(2,3-epoxypropoxy)butane; phenolic novolac type epoxy resin.
Precautionary statements
P261 – Avoid breathing dust/fume/gas/mist/vapours/spray. P264 – Wash hands, forearms and face thoroughly after handling. P280 – Wear protective gloves, protective clothing, eye protection, face protection, hearing protection. P312 – Call a POISON CENTRE or doctor if you feel unwell. P391 – Collect spillage.
Other hazards
Contains no PBT/vPvB substances > 0.1% assessed to REACH Annex XIII